| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |